Abstract
To the Editor: Total triiodothyronine (T3)1 (TT3) measurements can provide clinical utility elucidating T3-dominant Graves' disease and other thyrotoxicosis conditions. Thyroid hormone assays, including TT3, are susceptible to protein-based interferences, usually caused by endogenous antibodies. Interferences should be considered when the thyroid hormone concentrations are inconsistent with clinical impression (1). We detected an interference with the Ortho® Vitros TT3 assay causing falsely increased concentrations in 20 pediatric patients, some of whom had a history of high TT3 for years, suggesting that the interference was not limited to a single reagent lot. The erroneous results were questioned …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
